Overview Latest Regional Industry Featured Multimedia Other Languages Public Company News
Innovent Announces First Patient Dosing of Universal "Modular" CAR-T Cell product IBI345 2022-02-21 08:00
Seegene Announces Q4 and Full-Year 2021 Financial Results 2022-02-17 20:00
Small Molecule Targeting CD47-SIRPα Pathway: Insilico Medicine Achieves its First Major Milestone in Fosun Pharma Collaboration with the Nomination of Preclinical Candidate for QPCTL 2022-02-17 16:30
Kato Wins FDA Approval for Human Studies of Drug for Retinal Disorders 2022-02-17 12:14
CStone Pharmaceuticals Announces the Acceptance of New Drug Application (NDA) for Pralsetinib for the Treatment of RET Fusion-Positive Non-Small Cell Lung Cancer (NSCLC) and RET-Altered Thyroid Cancers in Taiwan, China 2022-02-17 09:19
Innovent Announces Two Registration Studies of IBI306 (anti-PCSK-9 antibody) Met Primary Endpoint 2022-02-17 08:00
BIOVAXYS ANNOUNCES complete inhibition of ACE-2 binding activity of hapten-modified SARS-CoV-2 protein 2022-02-16 21:00
JIXING ANNOUNCES RECEIPT OF BREAKTHROUGH THERAPY DESIGNATION FOR AFICAMTEN IN CHINA 2022-02-16 18:06
Sirnaomics Receives Safe to Proceed Letter for U.S. FDA Investigational New Drug Application for Systemic RNAi Therapeutic STP707 in Primary Sclerosing Cholangitis (PSC) 2022-02-16 17:04
NIBIOHN, Shionogi Discover Host Immune-dependent Novel Anti-coronavirus Antibody 2022-02-16 14:00
A Breakthrough in Probiotic Therapy - Personalized Probiotics (Dispensing) Machine for a Balanced and Enhanced Immune System 2022-02-16 10:00
Travecta Therapeutics Appoints Leading Experts to Expand its Scientific Advisory Leadership Team 2022-02-15 21:00
HPG: New Breakthrough in Virus Inactivation with Green Tea Catechin (EGCg) 2022-02-15 16:00
G-NiiB probiotics - world's first microbiome-based immunity formulas now available at IMI 2022-02-15 09:30
Shanghai Public Health Clinical Center Initiated Functional Cure Study of Anti-PD-L1 Antibody ASC22 (Envafolimab) in Combination With Chidamide in HIV-Infected Patients 2022-02-14 17:34
U.S. FDA Grants Orphan Drug Designation to BCMA CAR-T Cell Therapy Co-Developed by Innovent and IASO Bio 2022-02-14 08:00
Ascletis Announces Submission of Marketing Authorization Applications for Ritonavir in Multiple European Countries 2022-02-13 18:30
Novavax Announces Positive Results of COVID-19 Vaccine in Pediatric Population of PREVENT-19 Phase 3 Clinical Trial 2022-02-11 10:45
FDA Advisory Committee Votes to Recommend Additional Data for Sintilimab Submission 2022-02-11 10:44
Alphamab Oncology Announced IND Approval of PD-L1/OX40 Bispecific Antibody KN052 2022-02-11 09:31
1 87 88 89 90 91 230